[HTML][HTML] Tumor-associated macrophages regulate PD-1/PD-L1 immunosuppression
Y Pu, Q Ji - Frontiers in immunology, 2022 - frontiersin.org
Anti-programmed cell death 1 (PD-1) or anti-PD-ligand (L) 1 drugs, as classic immune
checkpoint inhibitors, are considered promising treatment strategies for tumors. In clinical …
checkpoint inhibitors, are considered promising treatment strategies for tumors. In clinical …
Sarcoma treatment in the era of molecular medicine
Sarcomas are heterogeneous and clinically challenging soft tissue and bone cancers.
Although constituting only 1% of all human malignancies, sarcomas represent the second …
Although constituting only 1% of all human malignancies, sarcomas represent the second …
[HTML][HTML] Advances in immunology and immunotherapy for mesenchymal gastrointestinal cancers
Mesenchymal gastrointestinal cancers are represented by the gastrointestinal stromal
tumors (GISTs) which occur throughout the whole gastrointestinal tract, and affect human …
tumors (GISTs) which occur throughout the whole gastrointestinal tract, and affect human …
BRD4 in physiology and pathology:''BET''on its partners
Y Liang, J Tian, T Wu - Bioessays, 2021 - Wiley Online Library
Abstract Bromodomain‐containing 4 (BRD4), a member of Bromo and Extra‐Terminal (BET)
family, recognizes acetylated histones and is of importance in transcription, replication, and …
family, recognizes acetylated histones and is of importance in transcription, replication, and …
[HTML][HTML] Tumor-associated macrophages mediate resistance of EGFR-TKIs in non-small cell lung cancer: mechanisms and prospects
D Cheng, K Ge, X Yao, B Wang, R Chen… - Frontiers in …, 2023 - frontiersin.org
Epidermal growth factor receptor tyrosine kinase inhibitors (EGFR-TKIs) are the first-line
standard treatment for advanced non-small cell lung cancer (NSCLC) with EGFR mutation …
standard treatment for advanced non-small cell lung cancer (NSCLC) with EGFR mutation …
[HTML][HTML] KIT mutations and expression: current knowledge and new insights for overcoming IM resistance in GIST
S Zhou, O Abdihamid, F Tan, H Zhou, H Liu, Z Li… - Cell Communication and …, 2024 - Springer
Gastrointestinal stromal tumor (GIST) is the most common sarcoma located in
gastrointestinal tract and derived from the interstitial cell of Cajal (ICC) lineage. Both ICC …
gastrointestinal tract and derived from the interstitial cell of Cajal (ICC) lineage. Both ICC …
[HTML][HTML] MiR-101-containing extracellular vesicles bind to BRD4 and enhance proliferation and migration of trophoblasts in preeclampsia
J Cui, X Chen, S Lin, L Li, J Fan, H Hou, P Li - Stem cell research & …, 2020 - Springer
Background Preeclampsia (PE) is a frequently occurring pregnancy disorder in the placenta,
which results in various maternal and fetal complications. The current study aims to evaluate …
which results in various maternal and fetal complications. The current study aims to evaluate …
[HTML][HTML] Therapeutic approaches targeting proteins in tumor-associated macrophages and their applications in cancers
D Wu, X Liu, J Mu, J Yang, F Wu, H Zhou - Biomolecules, 2022 - mdpi.com
Tumor-associated macrophages (TAMs) promote tumor proliferation, invasion,
angiogenesis, stemness, therapeutic resistance, and immune tolerance in a protein …
angiogenesis, stemness, therapeutic resistance, and immune tolerance in a protein …
[HTML][HTML] The tumor microenvironment of medulloblastoma: an intricate multicellular network with therapeutic potential
NFHN van Bree, M Wilhelm - Cancers, 2022 - mdpi.com
Simple Summary The current treatment options for medulloblastoma, the most common
malignant childhood brain cancer, are associated with many negative side effects and …
malignant childhood brain cancer, are associated with many negative side effects and …
Tumor-derived CC motif ligand 2 induces the recruitment and polarization of tumor-associated macrophages and increases the metastatic potential of bladder cancer …
Y Chiang, YC Tsai, CC Wang, FJ Hsueh… - International Journal of …, 2022 - Elsevier
Purpose Radiation therapy (RT) is mainly used for bladder preservation in patients with
muscle-invasive bladder cancer. The response of urothelial tumors to RT remains …
muscle-invasive bladder cancer. The response of urothelial tumors to RT remains …